Skip to main navigation Skip to search Skip to main content

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial

  • Yaacov Frishberg
  • , Wesley Hayes
  • , Hadas Shasha-Lavsky
  • , David J. Sas
  • , Mini Michael
  • , Anne Laure Sellier-Leclerc
  • , Julien Hogan
  • , Richard Willey
  • , John M. Gansner
  • , Daniella Magen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry